- B55.2 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2024 edition of ICD-10-CM B55.2 became effective on October 1, 2022.
- This is the American ICD-10-CM version of B55.2 – other international versions of ICD-10 B55.2 may differ.
ICD-10-CM B55.2 is grouped within Diagnostic Related Group(s):
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2016 (effective 10/1/2015): No change
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2024 (effective 10/1/2022): No change
Diagnosis Index entries containing back-references to B55.2:
- leishmaniasis > American
- mucocutaneous leishmaniasis > due to
- mucocutaneous leishmaniasis > in (due to) B60.12
- mucocutaneous leishmaniasis > parasitic B74.9
- braziliensis > Leishmania B55.1
- American (mucocutaneous) > Leishmaniasis B55.9
- Brazilian > Leishmaniasis B55.9
- mucocutaneous (American) (New World) > Leishmaniasis B55.9
- naso-oral > Leishmaniasis B55.9
- nasopharyngeal > Leishmaniasis B55.9